Juan Antonio Arroyo

1.4k total citations
23 papers, 701 citations indexed

About

Juan Antonio Arroyo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Juan Antonio Arroyo has authored 23 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Infectious Diseases. Recurrent topics in Juan Antonio Arroyo's work include Blood Pressure and Hypertension Studies (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Juan Antonio Arroyo is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Juan Antonio Arroyo collaborates with scholars based in Spain, Canada and United States. Juan Antonio Arroyo's co-authors include Peré Domingo, J. Scott Tonigan, María Larrousse, Roberto Belvís, Carmen García‐Sánchez, Virginia Pomar, Beatriz Gómez‐Ansón, Marco Calabria, Noemí Morollón and M. A. Sambeat and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Juan Antonio Arroyo

21 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Antonio Arroyo Spain 15 195 182 133 133 132 23 701
Josefina Robertson Sweden 12 65 0.3× 87 0.5× 218 1.6× 12 0.1× 164 1.2× 32 613
Jean‐Marc Lacombe France 11 18 0.1× 103 0.6× 182 1.4× 53 0.4× 69 0.5× 20 602
Raden Ayu Tuty Kuswardhani Indonesia 12 139 0.7× 186 1.0× 41 0.3× 25 0.2× 72 0.5× 44 602
Grace Lee United States 14 20 0.1× 98 0.5× 16 0.1× 60 0.5× 87 0.7× 41 532
Jonothan C. Tierce United States 13 46 0.2× 136 0.7× 40 0.3× 27 0.2× 83 0.6× 23 888
Angelique Mavrodaris United Kingdom 8 36 0.2× 31 0.2× 24 0.2× 22 0.2× 80 0.6× 15 689
Faraaz Shah United States 15 63 0.3× 81 0.4× 25 0.2× 48 0.4× 230 1.7× 43 766
M. E. Edmunds United Kingdom 13 18 0.1× 64 0.4× 83 0.6× 67 0.5× 78 0.6× 34 783
Mohammad Sobhan Sheikh Andalibi Iran 11 54 0.3× 22 0.1× 72 0.5× 23 0.2× 113 0.9× 34 438
Jeremy Roberts United States 14 14 0.1× 101 0.6× 92 0.7× 64 0.5× 57 0.4× 20 1.2k

Countries citing papers authored by Juan Antonio Arroyo

Since Specialization
Citations

This map shows the geographic impact of Juan Antonio Arroyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Antonio Arroyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Antonio Arroyo more than expected).

Fields of papers citing papers by Juan Antonio Arroyo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Antonio Arroyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Antonio Arroyo. The network helps show where Juan Antonio Arroyo may publish in the future.

Co-authorship network of co-authors of Juan Antonio Arroyo

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Antonio Arroyo. A scholar is included among the top collaborators of Juan Antonio Arroyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Antonio Arroyo. Juan Antonio Arroyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Sánchez, Carmen, Juan Antonio Arroyo, Beatriz Gómez‐Ansón, et al.. (2024). Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints. PLoS ONE. 19(8). e0302415–e0302415. 1 indexed citations
2.
Calabria, Marco, Carmen García‐Sánchez, Juan Antonio Arroyo, et al.. (2022). Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. Journal of Neurology. 269(8). 3990–3999. 69 indexed citations
3.
García‐Sánchez, Carmen, Marco Calabria, Juan Antonio Arroyo, et al.. (2022). Neuropsychological deficits in patients with cognitive complaints after COVID‐19. Brain and Behavior. 12(3). e2508–e2508. 92 indexed citations
4.
Marquès, Montse, Eudald Correig, Daiana Ibarretxe, et al.. (2021). Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality. Environment International. 158. 106930–106930. 37 indexed citations
5.
Castelblanco, Esmeralda, Lucía Sanjurjo, Marta Hernández, et al.. (2020). The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 9(6). 1700–1700. 5 indexed citations
6.
Torres, Olga H., Xavier Vidal, Antònia Agustí, et al.. (2017). Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study. Drugs & Aging. 34(6). 453–466. 23 indexed citations
7.
Sole, María José Del, et al.. (2015). Differences in the reduction of blood pressure according to drug administration at activity hours or rest hours. Medicina Clínica (English Edition). 144(2). 51–54. 1 indexed citations
8.
Arroyo, Juan Antonio, et al.. (2014). Diferencias en la reducción de la presión arterial en función de la toma de la medicación en horario diurno o nocturno. Medicina Clínica. 144(2). 51–54. 2 indexed citations
9.
Oliveras, Anna, Pedro Armario, Cristina Sierra, et al.. (2013). Urinary Albumin Excretion at Follow-Up Predicts Cardiovascular Outcomes in Subjects With Resistant Hypertension. American Journal of Hypertension. 26(9). 1148–1154. 10 indexed citations
10.
Martín‐Campos, Jesús M., et al.. (2011). Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Clinica Chimica Acta. 413(5-6). 552–555. 53 indexed citations
11.
Oliveras, Anna, Pedro Armario, Juan Antonio Arroyo, et al.. (2009). Urinary albumin excretion is associated with true resistant hypertension. Journal of Human Hypertension. 24(1). 27–33. 45 indexed citations
12.
Serrano‐Castro, Pedro J., et al.. (2007). Bilateral Bell Palsy and Acute HIV Type 1 Infection: Report of 2 Cases and Review. Clinical Infectious Diseases. 44(6). e57–e61. 36 indexed citations
13.
Moreno‐Torres, Àngel, Peré Domingo, Jesús Pujol Salud, et al.. (2007). Liver Triglyceride Content in HIV-1-Infected Patients on Combination Antiretroviral Therapy Studied with 1H-MR Spectroscopy. Antiviral Therapy. 12(2). 195–204. 19 indexed citations
14.
Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations
15.
Martínez, Estebán, Peré Domingo, Marı́a José Galindo, et al.. (2004). Risk of Metabolic Abnormalities in Patients Infected with HIV Receiving Antiretroviral Therapy that Contains Lopinavir‐Ritonavir. Clinical Infectious Diseases. 38(7). 1017–1023. 62 indexed citations
16.
Martínez, Estebán, Peré Domingo, Esteban Ribera, et al.. (2003). Effects of Metformin Or Gemfibrozil on the Lipodystrophy of HIV-Infected Patients Receiving Protease Inhibitors. Antiviral Therapy. 8(5). 403–410. 29 indexed citations
17.
Domingo, Peré, Xavier Matías‐Guiu, Ramón M. Pujol, et al.. (2001). Switching to Nevirapine Decreases Insulin Levels but Does Not Improve Subcutaneous Adipocyte Apoptosis in Patients with Highly Active Antiretroviral Therapy–Associated Lipodystrophy. The Journal of Infectious Diseases. 184(9). 1197–1201. 45 indexed citations
18.
Arroyo, Juan Antonio, et al.. (1998). Comparison of treatment utilization and outcome for Hispanics and non-Hispanic whites.. Journal of Studies on Alcohol. 59(3). 286–291. 64 indexed citations
19.
Arroyo, Juan Antonio, et al.. (1996). Alcohol, drug use and consequences among Hispanics seeking treatment for alcohol-related problems.. Journal of Studies on Alcohol. 57(6). 613–618. 23 indexed citations
20.
Pou, José María, et al.. (1991). Effect of <i>L</i>-Asparaginase on Insulin Secretion from Isolated Rat Islets of Langerhans. Hormone Research. 35(3-4). 155–160. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josefina Robertson Breakdown of academic impact, for papers by Jean‐Marc Lacombe Breakdown of academic impact, for papers by Raden Ayu Tuty Kuswardhani Breakdown of academic impact, for papers by Grace Lee Breakdown of academic impact, for papers by Jonothan C. Tierce Breakdown of academic impact, for papers by Angelique Mavrodaris Breakdown of academic impact, for papers by Faraaz Shah Breakdown of academic impact, for papers by M. E. Edmunds Breakdown of academic impact, for papers by Mohammad Sobhan Sheikh Andalibi Breakdown of academic impact, for papers by Jeremy Roberts
Rankless by CCL
2026